Orforglipron (Foundayo): The Oral GLP-1 Pill Explained

Orforglipron Foundayo guide from CuraPhyx Pharmacy
What orforglipron (Foundayo) is, who it is for, how you take it, trial results, side effects and UK availability.

Orforglipron is a new weight loss medicine that you take as a daily tablet rather than an injection. It’s sold under the brand name Foundayo. In August 2026, the UK medicines regulator, the MHRA, authorised it for weight management and type 2 diabetes. That made the UK the first country in Europe to approve it.

This guide explains what orforglipron is, who it’s for, how you take it, what the trials found and the side effects to know about. It uses the MHRA’s announcement, the official product information and published trial results. It’s for general information only. Foundayo is a prescription-only medicine, so a prescriber decides whether it’s suitable for you.

Orforglipron at a glance

Key takeaways

  • Orforglipron (Foundayo) is a once-daily GLP-1 tablet for weight management and type 2 diabetes.
  • You can take it at any time of day, with no food or water rules.
  • The dose starts low and rises in steps, with at least a month at each dose.
  • The most common side effects are nausea, constipation, diarrhoea, vomiting, indigestion and stomach pain.
  • It’s licensed in the UK but isn’t currently available on the NHS.

What Is Orforglipron?

Orforglipron belongs to a group of medicines called GLP-1 receptor agonists. These copy a natural gut hormone called glucagon-like peptide-1 (GLP-1). Your body releases this hormone after you eat.

Other GLP-1 medicines, such as semaglutide (Wegovy), are larger, protein-like molecules. Most of them are given as injections. By contrast, orforglipron is a small molecule. This means it can be made as a tablet that your body absorbs from the gut.

Notably, it was developed by Eli Lilly, the company that also makes Mounjaro (tirzepatide).

How it helps with weight loss

According to the MHRA, it acts on areas of the brain that control appetite. As a result, it helps you feel fuller for longer, reduces hunger and lowers food cravings. It also slows how quickly food leaves your stomach. In people with type 2 diabetes, it lowers blood sugar when levels are high. Our guide to how the tablet works explains this in more detail.

Who Is Orforglipron For?

The MHRA has authorised it for weight loss and weight maintenance in adults with:

  • a body mass index (BMI) of 30 or above, or
  • a BMI between 27 and 30, plus at least one weight-related health problem

For example, weight-related health problems can include high blood pressure, high cholesterol, sleep apnoea and heart disease. Like other weight loss medicines, it’s meant to be used alongside a reduced-calorie diet and more physical activity.

Type 2 diabetes

It’s also authorised to improve blood sugar control in adults whose type 2 diabetes isn’t well controlled. If you take insulin or a sulphonylurea, such as gliclazide, your prescriber may need to lower that dose. This is because the combination can raise the risk of low blood sugar (hypoglycaemia).

Who shouldn’t take it

According to the product information, it isn’t suitable:

  • during pregnancy or breastfeeding
  • for children and young people under 18
  • if you have severe liver problems
  • if you’re allergic to any of its ingredients

It should also be used with caution if you’ve had pancreatitis, or if you have severe stomach or gut problems.

How Do You Take Orforglipron?

Simply put, you take one tablet once a day. The product information says you can take it at any time of day, without food or water restrictions. This is different from some other oral weight loss medicines, which must be taken on an empty stomach. Swallow the tablet whole. Don’t break, crush or chew it.

Orforglipron dose steps

First, treatment starts at a low dose and increases slowly. This gives your body time to adjust and helps reduce stomach side effects. The doses are:

Step Daily dose
Month 1 (starting dose) 0.8mg
Month 2 at the earliest 2.5mg
From month 3 at the earliest 5.5mg
If needed, then 9mg
Next option 14.5mg
Highest dose 17.2mg

In general, you stay on each dose for at least 30 days. After 5.5mg, your prescriber decides whether to increase further, based on how well it’s working and how you feel. Never take more than one tablet a day to reach a higher dose.

If you miss a dose

The product information says to take it as soon as possible. However, never take more than one tablet in a day.

What Did the Trials Show?

The main weight loss trial was ATTAIN-1. It included 3,127 adults with obesity, or overweight plus a weight-related health problem, but without diabetes. Everyone also had advice on diet and exercise. The trial lasted 72 weeks.

The product information reports these average weight changes:

Group Average weight change
Placebo (dummy tablet) -0.9%
Lower dose -7.8%
Middle dose -9.3%
Highest dose -12.4%

In the highest dose group, about 6 in 10 people lost at least 10% of their body weight. Even so, results vary from person to person. Some people lose more weight, and others lose less.

Diabetes trials

In the ACHIEVE programme, the tablet lowered blood sugar in people with type 2 diabetes. It also led to weight loss.

How does it compare with injections?

There haven’t been head-to-head trials against Mounjaro or Wegovy for weight loss. So, the results can’t be compared directly. Our comparison with Mounjaro and Wegovy looks at what we do and don’t know.

Orforglipron Side Effects

The MHRA says the most common side effects are:

  • feeling sick (nausea)
  • constipation
  • diarrhoea
  • being sick (vomiting)
  • indigestion
  • stomach pain

These are most likely when you start or move up a dose. In the trials, they were mostly mild or moderate and eased over time.

The product information lists other effects too, such as headache, dizziness, tiredness, bloating, burping, wind, reflux, a faster heart rate, low blood pressure and some hair loss.

Serious side effects

Rarely, GLP-1 medicines can cause inflammation of the pancreas (pancreatitis). Get urgent help if you have severe stomach pain that won’t go away, which may spread to your back. Also get help for:

  • severe or ongoing vomiting or diarrhoea, which can lead to dehydration
  • pain in the upper right side of your tummy, a fever or yellow skin, which can be signs of gallstones
  • signs of a severe allergic reaction

Our side effects guide for this tablet covers these in more detail. You can report side effects to the MHRA Yellow Card scheme.

Operations and sedation

GLP-1 medicines slow how fast your stomach empties. So, tell your medical team you take it before any surgery or procedure under sedation.

Orforglipron, Contraception and Pregnancy

This is an important point. The product information says orforglipron may make the contraceptive pill less effective. If you take the pill, you should switch to a non-oral method, such as a coil or implant, or add a barrier method like condoms. Do this for 30 days after starting, and for 30 days after each dose increase.

You shouldn’t take it if you’re pregnant. If you’re planning a pregnancy, stop taking it at least 3 weeks beforehand. This gives it time to leave your body. In addition, the MHRA advises using effective contraception while taking any GLP-1 medicine for weight loss.

Orforglipron and Other Medicines

In addition, some medicines can change the level of orforglipron in your blood. For example, the product information mentions:

  • certain antibiotics and HIV medicines, which can raise levels
  • some epilepsy medicines, rifampicin and St John’s wort, which can lower levels
  • some statins, such as rosuvastatin, where extra care is needed

So, tell your prescriber about every medicine and supplement you take.

Is Orforglipron Available on the NHS?

Not at the moment. The MHRA says that, although it’s approved for use in the UK, it isn’t currently available on the NHS. The National Institute for Health and Care Excellence (NICE) is assessing it for managing overweight and obesity. NICE will then decide whether the NHS should offer it.

Buying it safely

Like all GLP-1 medicines, it’s prescription-only. The MHRA warns that buying GLP-1 medicines from unregulated sellers carries serious health risks. Only get them from a registered pharmacy, with a prescription.

Lifestyle Still Matters

Of course, medicine works best alongside healthy habits. The trials paired it with advice on diet and activity. Helpful steps include:

  • eating smaller portions, with plenty of vegetables, protein and fibre
  • drinking enough water, especially if you have sickness or diarrhoea
  • being active most days, including some strength exercises
  • getting enough sleep

Our guide to lifestyle changes with weight loss medication has more tips.

FAQs About Orforglipron

Is Foundayo the same as orforglipron?

Yes. Orforglipron is the medicine’s generic name, and Foundayo is its brand name.

Is it a weight loss injection?

No. It’s a tablet that you swallow once a day.

How much weight could I lose?

In ATTAIN-1, people on the highest dose lost 12.4% of their body weight on average over 72 weeks. However, results vary a lot between people.

Do I need to take it with food?

No. You can take it at any time of day, with or without food or water.

Can I take it if I have type 2 diabetes?

It’s authorised for type 2 diabetes too. However, your prescriber may need to adjust your other diabetes medicines.

Summary

Orforglipron (Foundayo) is a once-daily GLP-1 tablet for weight management and type 2 diabetes. The MHRA authorised it in August 2026. You can take it at any time of day, with no food or water rules, and the dose rises slowly over several months. The main trial showed average weight loss of 12.4% at the highest dose. The most common side effects affect the stomach and gut. It’s prescription-only, needs extra contraception care, and isn’t currently on the NHS.

About CuraPhyx Pharmacy

CuraPhyx Pharmacy is a UK pharmacy. A qualified pharmacist or prescriber reviews every request for a prescription medicine and decides whether it’s suitable. You can read more on our weight loss page. If you have questions, you can email info@curaphyx.co.uk.

Sources and Further Reading

We checked this article against the following sources in October 2026:

This article is for general information only. It doesn’t replace advice from your GP, pharmacist or prescriber. Foundayo (orforglipron) is a prescription-only medicine, so a prescriber must decide whether it is suitable for you. Always read the patient information leaflet that comes with your medicine. Last reviewed: October 2026.

Share the Post:

Related Posts